Source: Annual Congress 2012 - New biomarkers for lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
D. Yang, X. Wang, T. Zeng, J. Hu, Y. Song, L. Chen, X. Wang, C. Bai (Shanghai, China). Alterations of serum inflammatory biomarkers in the healthy and lung cancer patients before and post chemotherapy. Eur Respir J 2012; 40: Suppl. 56, 4207

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of serum tumour markers in the lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 268s Year: 2002 Serum tumor markers in lung cancer patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007 Serum levels of TGFβ and VEGF in lung cancer patients and healthy subjects Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004 Elevation of serum tumor markers in patients with interstitial lung disease Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Pleural and systemic cytokine expression profiles in patients with lung cancer Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006 The clinicofunctional features of patients with lung cancer and secondary inflammatory changes Source: Eur Respir J 2006; 28: Suppl. 50, 782s Year: 2006 CEA levels in the serum and induced sputum of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Evaluation of serum levels of Sirtuin-1 in lung cancer patients Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Elevated serum levels of oxidative stress biomarkers in patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy Source: Eur Respir Rev 2013; 22: 565-576 Year: 2013 Tumor markers in bronchial secretions and serum in patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 76s Year: 2004 Changes in lung function tests in lung carcinoma patients due to radiotherapy Source: Eur Respir J 2001; 18: Suppl. 33, 221s Year: 2001 How to evaluate the immune status of lung cancer patients before immunotherapy Source: Breathe, 13 (4) 291; 10.1183/20734735.001917 Year: 2017 Increase of skin reactivity to histamine after chemotherapy in patients with lung cancer Source: Annual Congress 2007 - Therapy of lung cancer Year: 2007 C-reactive protein and assessment of chemotherapy response in advanced non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Prognostic value of il-6 and TNF-alfa serum concentration in advanced non-small lung cancer patients Source: Eur Respir J 2003; 22: Suppl. 45, 251s Year: 2003 Evaluation expression of miR-146a and miR-155 and inflammatory  cytokines in blood of non-small cell lung cancer patients Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021